HPLC Verified
Purity confirmed by High-Performance Liquid Chromatography at an accredited EU laboratory.

10mg mitochondrial research peptide
MOTS-c — Mitochondrial Open Reading Frame of the 12S rRNA type-c — is a sixteen-amino-acid peptide encoded not within the nuclear genome, as was long assumed for all bioactive peptides, but within the mitochondrial genome itself. Its discovery in 2015 by Changhan David Lee and colleagues fundamentally challenged the canonical view of mitochondrial DNA as a passive archive encoding only respiratory chain components.
The mitochondrial genome encodes only thirteen protein-coding genes — all components of the oxidative phosphorylation machinery — along with ribosomal RNAs and transfer RNAs. Within the 12S ribosomal RNA gene, Lee's group identified a conserved open reading frame encoding MOTS-c. The finding that a small, secreted peptide with hormone-like systemic effects could originate from the mitochondrial genome opened an entirely new class of signalling molecules: mitochondrial-derived peptides (MDPs), of which MOTS-c is the most extensively characterised member.
The foundational 2015 Cell Metabolism paper by Lee and colleagues demonstrated that MOTS-c administration in high-fat-diet-fed mice improved insulin sensitivity, reduced fat accumulation, and enhanced glucose tolerance — effects mediated largely through activation of the AMPK pathway and downstream effects on the folate cycle and de novo purine synthesis. A striking feature of the paper was the demonstration that MOTS-c translocates from mitochondria to the nucleus in response to metabolic stress, where it appears to regulate AMPK-target gene expression directly.
A 2021 Nature Communications paper by Reynolds and colleagues demonstrated that MOTS-c levels in blood increase in response to physical exercise in both mice and humans, and that MOTS-c administration in aged mice improved physical performance markers including grip strength, endurance capacity, and lean body mass — phenotypes consistent with attenuation of age-associated muscle decline. The authors proposed that MOTS-c functions as an exercise-induced mitokine, communicating mitochondrial metabolic status to peripheral tissues to coordinate systemic adaptation.
Circulating MOTS-c levels in humans decline with age, parallel to the broader pattern of mitochondrial dysfunction in ageing tissues. Genetic association studies have identified MOTS-c sequence variants enriched in centenarian populations in multiple ethnic cohorts, suggesting a potential role for MOTS-c signalling in human longevity biology. The precise mechanisms by which MOTS-c intersects with established ageing pathways — including mTOR, FOXO, and mitochondrial quality control — remain active areas of investigation.
This content is for informational purposes only and reflects the state of preclinical research. It does not constitute medical advice, endorsement of human use, or therapeutic claims of any kind.
Purity confirmed by High-Performance Liquid Chromatography at an accredited EU laboratory.
Every batch meets or exceeds 98% purity. CoA available for verification before dispatch.
Each vial is traceable to its synthesis batch, testing date, and analytical records.
European stock stored at optimal temperature from synthesis to dispatch.
Orders ship from EU stock within 48 hours with discrete, temperature-appropriate packaging.
Certificate of Analysis issued for every batch, available for download on request.
Peer-reviewed research supporting MOTS-c investigation.
Discovery paper establishing MOTS-c as a functional mitochondrial-encoded peptide with systemic metabolic effects. Administration to high-fat-diet mice improved insulin sensitivity, reduced adiposity, and enhanced glucose tolerance. Mechanistic studies identified AMPK activation and folate/purine cycle modulation as downstream mediators. Nuclear translocation of MOTS-c under metabolic stress was demonstrated for the first time.
View on PubMedLandmark study demonstrating that MOTS-c circulating levels increase during exercise in humans and mice, and that exogenous MOTS-c administration improves physical performance in aged mice — including grip strength and endurance — without observed adverse effects. The study positions MOTS-c as an exercise-induced mitokine with potential relevance to sarcopenia and musculoskeletal ageing research.
View on PubMedA comprehensive review contextualising MOTS-c within the broader class of mitochondrial-derived peptides (MDPs) including humanin and SHLP1-6. The authors examine mechanisms of MDP secretion, receptor identification, and downstream signalling, providing a framework for understanding how mitochondrial genome-encoded signals coordinate systemic metabolic physiology.
View on PubMedGenetic association study identifying a naturally occurring variant in the MOTS-c coding sequence (m.1382 A>C) that produces a non-synonymous amino acid change in the encoded peptide. The variant allele is associated with increased type 2 diabetes risk in Japanese cohorts, providing human genetic evidence for MOTS-c's role in metabolic regulation.
View on PubMedAll studies referenced are independent third-party research. UNIK LAB makes no claims regarding the therapeutic efficacy of any compound and does not represent or endorse the conclusions of cited studies. All referenced research was conducted under controlled laboratory or clinical conditions; results may not be predictive of effects in other experimental contexts.
Answers to the most frequently asked questions about MOTS-c.
Other Metabolic research compounds from our catalogue.
MOTS-c is encoded within the mitochondrial 12S rRNA gene, making it the first peptide hormone discovered to originate from the mitochondrial genome rather than nuclear DNA. This discovery established a new class of signalling molecules — mitochondrial-derived peptides (MDPs) — with systemic hormone-like effects.
MOTS-c activates AMPK and modulates the folate cycle and de novo purine synthesis pathway. Under metabolic stress, MOTS-c translocates from mitochondria to the nucleus, where it directly regulates AMPK-target gene transcription — a unique mechanism linking mitochondrial status to nuclear gene expression.
Circulating MOTS-c levels increase in response to aerobic exercise in both humans and mice, positioning it as a bona fide exercise-induced mitokine. Administration of MOTS-c in aged mice reproduces elements of systemic metabolic exercise adaptation, making it a valuable tool for studying exercise biology in ageing contexts.
In high-fat-diet rodent models, MOTS-c administration improves glucose tolerance, reduces adiposity, and enhances insulin sensitivity via AMPK/GLUT4 signalling. These metabolic effects have generated interest in MOTS-c as a research tool for studying the intersection of mitochondrial signalling and metabolic disease.
Circulating MOTS-c levels decline with age in humans, and genetic variants in the MOTS-c coding sequence are enriched in centenarian populations across multiple ethnic cohorts. In aged mouse models, MOTS-c administration improves grip strength and endurance capacity, supporting its relevance to sarcopenia and musculoskeletal ageing research.
MOTS-c is encoded within mitochondrial DNA — specifically within the 12S ribosomal RNA gene — making it one of the first peptide hormones discovered to originate from the mitochondrial genome rather than the nuclear genome. Prior to its discovery in 2015, it was assumed that all bioactive signalling peptides were encoded in the cell's nuclear DNA. MOTS-c belongs to a new class of molecules now termed mitochondrial-derived peptides (MDPs).
The primary documented pathway is AMPK (AMP-activated protein kinase) activation, which in turn affects downstream targets including PGC-1α (mitochondrial biogenesis), GLUT4 translocation (glucose uptake), and ACC inhibition (fatty acid synthesis). MOTS-c also appears to modulate the folate cycle and de novo purine biosynthesis, which may contribute to its effects on nucleotide availability and gene expression. Additionally, MOTS-c translocates to the nucleus under metabolic stress, where it directly influences AMPK-target gene transcription.
Circulating MOTS-c levels increase in response to aerobic exercise in both humans and mice, suggesting it functions as an exercise-induced mitokine — a peptide secreted from mitochondria to communicate the cell's metabolic state to peripheral tissues. Research has shown that MOTS-c administration reproduces some of the systemic metabolic benefits of exercise in rodent models, positioning it as a potential tool for studying exercise adaptation pathways, particularly in the context of ageing.
Lyophilised MOTS-c should be stored at 2–8°C in sealed vials protected from light and moisture. As a 16-residue peptide of moderate size, it is moderately stable but sensitive to oxidation of its methionine residue. Reconstitution should be in sterile bacteriostatic water or PBS; solutions should be aliquoted and stored at 2–8°C for extended use, or at 2–8°C for use within 2 weeks. Avoid repeated freeze-thaw cycles.
Yes. Plasma MOTS-c has been quantified in human subjects using immunoassay and mass spectrometry methods. Studies report age-associated decline in circulating MOTS-c levels and exercise-induced increases. Genetic variants in the MOTS-c coding sequence (within mitochondrial DNA) have been associated with metabolic disease risk in population genetics studies, providing direct human relevance for the preclinical findings.
UNIK LAB's MOTS-c achieves ≥98% purity by HPLC with MS identity confirmation verifying the molecular weight of 2,174.5 Da. Given the methionine-containing sequence, we also verify the oxidation state of the methionine residue. Full CoA with HPLC chromatogram, MS data, and batch number is provided with each order.
Common in vitro models include 3T3-L1 adipocytes and L6/C2C12 skeletal muscle cells for metabolic endpoint studies, and primary hepatocytes for glucose and lipid metabolism assays. In vivo models include diet-induced obese (DIO) mice, high-fat diet rodents, and aged mouse cohorts for studies of physical performance and metabolic function. Reporter assays for AMPK activation and nuclear translocation use HEK293 or primary cell lines with fluorescent fusion constructs.